Correction: miR-509-3p is clinically significant and strongly attenuates cellular migration and multi-cellular spheroids in ovarian cancer.
Pan Y, Robertson G, Pedersen L, Lim E, Hernandez-Herrera A, Rowat AC, Patil SL, Chan CK, Wen Y, Zhang X, Basu-Roy U, Mansukhani A, Chu A, Sipahimalani P, Bowlby R, Brooks D, Thiessen N, Coarfa C, Ma Y, Moore RA, Schein JE, Mungall AJ, Liu J, Pecot CV, Sood AK, Jones SJ, Marra MA, Gunaratne PH.
Pan Y, et al. Among authors: hernandez herrera a.
Oncotarget. 2017 Mar 7;8(10):17406. doi: 10.18632/oncotarget.15921.
Oncotarget. 2017.
PMID: 28403581
Free PMC article.
No abstract available.